Details of the Drug Formulations

General Information of Drug (ID: DMLUA9D)

Drug Name
Simeprevir Drug Info
Synonyms TMC436
Indication
Disease Entry ICD 11 Status REF
Chronic HCV-1 infection 1E51.1 Approved [1]
Renal hypoplasia Approved [2]
Therapeutic Class
Antiinfective Agents
Cross-matching ID
PubChem CID
24873435
ChEBI ID
CHEBI:134743
CAS Number
923604-59-5
TTD ID
D00TLP
VARIDT ID
DR00014
INTEDE ID
DR1484
ACDINA ID
D00623

Full List of Drug Formulations Containing This Drug

Simeprevir 150 mg capsule
Company Formulation ID FDA Description
Janssen Products F19950 Lactose monohydrate; Sodium lauryl sulfate; Magnesium stearate; Ferrosoferric oxide; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Gelatin, unspecified; Shellac
------------------------------------------------------------------------------------
Simeprevir Sodium eq 150mg base capsule
Company Formulation ID FDA Description
Janssen Prods F23355 Colloidal Anhydrous Silica; Croscarmellose Sodium; Lactose Monohydrate; Magnesium Stearate; Sodium Lauryl Sulphate; Gelatin; Titanium Dioxide (E171); Iron Oxide Black (E172); Shellac (E904)
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7367).
2 Simeprevir FDA Label